ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Nicorette® Invisi, transdermales Pflaster:JNTL Consumer Health II (Switzerland) GmbH
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 

Packungen

Nicorette Invisi Pflaster 10 mg/16 Std. (15,75 mg Nikotin), Phase 3: 14 Stück. [D]
Nicorette Invisi Pflaster 15 mg/16 Std. (23,62 mg Nikotin), Phase 2: 14 Stück. [D]
Nicorette Invisi Pflaster 25 mg/16 Std. (39,37 mg Nikotin), Phase 1: 14 Stück. [D]

2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home